RESUMO
Cognitive decline is a feared aspect of growing old. It is a major contributor to lower quality of life and loss of independence in old age. We investigated the genetic contribution to individual differences in nonpathological cognitive ageing in five cohorts of older adults. We undertook a genome-wide association analysis using 549 692 single-nucleotide polymorphisms (SNPs) in 3511 unrelated adults in the Cognitive Ageing Genetics in England and Scotland (CAGES) project. These individuals have detailed longitudinal cognitive data from which phenotypes measuring each individual's cognitive changes were constructed. One SNP--rs2075650, located in TOMM40 (translocase of the outer mitochondrial membrane 40 homolog)--had a genome-wide significant association with cognitive ageing (P=2.5 × 10(-8)). This result was replicated in a meta-analysis of three independent Swedish cohorts (P=2.41 × 10(-6)). An Apolipoprotein E (APOE) haplotype (adjacent to TOMM40), previously associated with cognitive ageing, had a significant effect on cognitive ageing in the CAGES sample (P=2.18 × 10(-8); females, P=1.66 × 10(-11); males, P=0.01). Fine SNP mapping of the TOMM40/APOE region identified both APOE (rs429358; P=3.66 × 10(-11)) and TOMM40 (rs11556505; P=2.45 × 10(-8)) as loci that were associated with cognitive ageing. Imputation and conditional analyses in the discovery and replication cohorts strongly suggest that this effect is due to APOE (rs429358). Functional genomic analysis indicated that SNPs in the TOMM40/APOE region have a functional, regulatory non-protein-coding effect. The APOE region is significantly associated with nonpathological cognitive ageing. The identity and mechanism of one or multiple causal variants remain unclear.
Assuntos
Envelhecimento/genética , Apolipoproteínas E/genética , Cognição/fisiologia , Polimorfismo de Nucleotídeo Único/genética , Estudos de Coortes , Inglaterra , Feminino , Frequência do Gene , Predisposição Genética para Doença , Estudo de Associação Genômica Ampla , Humanos , Desequilíbrio de Ligação , Masculino , Proteínas de Membrana Transportadoras/genética , Proteínas do Complexo de Importação de Proteína Precursora Mitocondrial , EscóciaRESUMO
Haw River Syndrome (HRS) is a dominant neurodegenerative disease that has affected five generations of an African-American family in rural North Carolina. The disorder represents a unique spectrum of multiple system degenerations resembling Huntington's disease, spinocerebellar atrophy and dentatorubropallidoluysian atrophy (DRPLA), a neurodegenerative disease that has been primarily reported in Japan. Recently, DRPLA has been shown to be due to an expanded trinucleotide repeat located on chromosome 12pter-p12. We have genotyped this family and found HRS to be tightly linked to the DRPLA region. Further examination demonstrates that, despite their distinct cultural origins and clinical and pathological differences, HRS is caused by the same expanded CTG-B37 repeat as DRPLA.
Assuntos
Encefalopatias/genética , Atrofia , População Negra/genética , Encefalopatias/patologia , Calcinose/genética , Núcleos Cerebelares/patologia , Cromossomos Humanos Par 12 , Feminino , Ligação Genética , Globo Pálido/patologia , Humanos , Masculino , Repetições Minissatélites , North Carolina , Oligodesoxirribonucleotídeos/genética , Linhagem , Núcleo Rubro/patologia , Sequências Repetitivas de Ácido Nucleico , SíndromeRESUMO
Autosomal recessive Duchenne-like muscular dystrophy (DLMD) is a severe dystrophic myopathy. The incidence is unknown because of its clinical similarity to Duchenne muscular dystrophy (DMD). Three highly inbred DLMD families from Tunisia were analysed for chromosomal linkage using 135 polymorphic microsatellite markers. A significant lod score of z = 9.15 at theta = 0.03 was found with the 13q12 locus D13S115. Two additional 13q12 markers, D13S143 and D13S120, also gave significant lod scores. Therefore, the primary DLMD defect gene lies in the pericentrometric region of chromosome 13q.
Assuntos
Cromossomos Humanos Par 13 , Ligação Genética , Distrofias Musculares/genética , Centrômero/ultraestrutura , Mapeamento Cromossômico , Cromossomos Humanos Par 13/ultraestrutura , Consanguinidade , DNA Satélite/genética , Feminino , Genes Recessivos , Marcadores Genéticos , Humanos , Masculino , Linhagem , Fenótipo , Polimorfismo Genético , TunísiaRESUMO
Multiple sclerosis (MS), an inflammatory autoimmune demyelinating disorder of the central nervous system, is the most common cause of acquired neurological dysfunction arising in the second to fourth decades of life. A genetic component to MS is indicated by an increased relative risk of 20-40 to siblings compared to the general population (lambda s), and an increased concordance rate in monozygotic compared to dizygotic twins. Association and/or linkage studies to candidate genes have produced many reports of significant genetic effects including those for the major histocompatability complex (MHC; particularly the HLA-DR2 allele), immunoglobulin heavy chain (IgH), T-cell receptor (TCR) and myelin basic protein (MBP) loci. With the exception of the MHC, however, these results have been difficult to replicate and/or apply beyond isolated populations. We have therefore conducted a two-stage, multi-analytical genomic screen to identify genomic regions potentially harbouring MS susceptibility genes. We genotyped 443 markers and 19 such regions were identified. These included the MHC region on 6p, the only region with a consistently reported genetic effect. However, no single locus generated overwhelming evidence of linkage. Our results suggest that a multifactorial aetiology, including both environmental and multiple genetic factors of moderate effect, is more likely than an aetiology consisting of simple mendelian disease gene(s).
Assuntos
Cromossomos Humanos Par 6 , Complexo Principal de Histocompatibilidade , Esclerose Múltipla/genética , Mapeamento Cromossômico/métodos , Cromossomos Humanos Par 7/genética , Ligação Genética , Marcadores Genéticos , Humanos , LinhagemRESUMO
Familial Alzheimer's disease (FAD) has been shown to be genetically heterogeneous, with a very small proportion of early onset pedigrees being associated with mutations in the amyloid precursor protein (APP) gene on chromosome 21, and some late onset pedigrees showing associations with markers on chromosome 19. We now provide evidence for a major early onset FAD locus on the long arm of chromosome 14 near the markers D14S43 and D14S53 (multipoint lod score z = 23.4) and suggest that the inheritance of FAD may be more complex than had initially been suspected.
Assuntos
Doença de Alzheimer/genética , Cromossomos Humanos Par 14 , Idoso , Alelos , Precursor de Proteína beta-Amiloide/genética , Sequência de Bases , Mapeamento Cromossômico , DNA/genética , Feminino , Marcadores Genéticos , Humanos , Escore Lod , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , LinhagemRESUMO
Major depressive disorder (MDD) is a highly prevalent disorder with substantial heritability. Heritability has been shown to be substantial and higher in the variant of MDD characterized by recurrent episodes of depression. Genetic studies have thus far failed to identify clear and consistent evidence of genetic risk factors for MDD. We conducted a genome-wide association study (GWAS) in two independent datasets. The first GWAS was performed on 1022 recurrent MDD patients and 1000 controls genotyped on the Illumina 550 platform. The second was conducted on 492 recurrent MDD patients and 1052 controls selected from a population-based collection, genotyped on the Affymetrix 5.0 platform. Neither GWAS identified any SNP that achieved GWAS significance. We obtained imputed genotypes at the Illumina loci for the individuals genotyped on the Affymetrix platform, and performed a meta-analysis of the two GWASs for this common set of approximately half a million SNPs. The meta-analysis did not yield genome-wide significant results either. The results from our study suggest that SNPs with substantial odds ratio are unlikely to exist for MDD, at least in our datasets and among the relatively common SNPs genotyped or tagged by the half-million-loci arrays. Meta-analysis of larger datasets is warranted to identify SNPs with smaller effects or with rarer allele frequencies that contribute to the risk of MDD.
Assuntos
Transtorno Depressivo Maior/genética , Estudo de Associação Genômica Ampla , População Branca/genética , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Europa (Continente) , Feminino , Genótipo , Humanos , Masculino , Metanálise como Assunto , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , RecidivaRESUMO
At least five adult-onset neurodegenerative diseases, including Huntingtin disease (HD), and dentatorubral-pallidoluysian atrophy (DRPLA) are produced by genes containing a variably increased CAG repeat within the coding region. The size range of the repeats is similar in all diseases; unaffected individuals have fewer than 30 CAG repeats, whereas affected patients usually have more than 40 repeats. The size of the inherited CAG repeat correlates with the severity and age of disease onset. The CAG triplet repeat produces a polyglutamine domain in the expressed proteins. All of these diseases are inherited in a dominant fashion, and a pathologic gain of function in gene carriers has been proposed. We sought to identify proteins in the brain that selectively interact with polyglutamine-domain proteins, hypothesizing that the polyglutamine domain may determine protein-protein interactions.
Assuntos
Gliceraldeído-3-Fosfato Desidrogenases/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Doenças do Sistema Nervoso/metabolismo , Proteínas Nucleares/metabolismo , Adulto , Sequência de Aminoácidos , Animais , Sítios de Ligação , Humanos , Proteína Huntingtina , Doença de Huntington/genética , Doença de Huntington/metabolismo , Técnicas In Vitro , Repetições Minissatélites , Dados de Sequência Molecular , Doenças do Sistema Nervoso/genética , Ligação Proteica , Coelhos , Repetições de TrinucleotídeosRESUMO
The É4 allele of the apolipoprotein E (APOE) gene is currently the strongest and most highly replicated genetic factor for risk and age of onset of late-onset Alzheimer's disease (LOAD). Using phylogenetic analysis, we have identified a polymorphic poly-T variant, rs10524523, in the translocase of outer mitochondrial membrane 40 homolog (TOMM40) gene that provides greatly increased precision in the estimation of age of LOAD onset for APOE É3 carriers. In two independent clinical cohorts, longer lengths of rs10524523 are associated with a higher risk for LOAD. For APOE É3/4 patients who developed LOAD after 60 years of age, individuals with long poly-T repeats linked to APOE É3 develop LOAD on an average of 7 years earlier than individuals with shorter poly-T repeats linked to APOE É3 (70.5 ± 1.2 years versus 77.6 ± 2.1 years, P=0.02, n=34). Independent mutation events at rs10524523 that occurred during Caucasian evolution have given rise to multiple categories of poly-T length variants at this locus. On replication, these results will have clinical utility for predictive risk estimates for LOAD and for enabling clinical disease prevention studies. In addition, these results show the effective use of a phylogenetic approach for analysis of haplotypes of polymorphisms, including structural polymorphisms, which contribute to complex diseases.
Assuntos
Doença de Alzheimer/epidemiologia , Doença de Alzheimer/genética , Predisposição Genética para Doença , Proteínas de Membrana Transportadoras/genética , Polimorfismo de Nucleotídeo Único , Idade de Início , Idoso , Idoso de 80 Anos ou mais , Apolipoproteína E3/genética , Apolipoproteína E4/genética , Estudos de Casos e Controles , Estudos de Coortes , DNA/genética , Feminino , Testes Genéticos , Humanos , Desequilíbrio de Ligação , Masculino , Proteínas do Complexo de Importação de Proteína Precursora Mitocondrial , Filogenia , Valor Preditivo dos Testes , RiscoRESUMO
AIMS/HYPOTHESIS: Several susceptibility genes for type 2 diabetes have been discovered recently. Individually, these genes increase the disease risk only minimally. The goals of the present study were to determine, at the population level, the risk of diabetes in individuals who carry risk alleles within several susceptibility genes for the disease and the added value of this genetic information over the clinical predictors. METHODS: We constructed an additive genetic score using the most replicated single-nucleotide polymorphisms (SNPs) within 15 type 2 diabetes-susceptibility genes, weighting each SNP with its reported effect. We tested this score in the extensively phenotyped population-based cross-sectional CoLaus Study in Lausanne, Switzerland (n = 5,360), involving 356 diabetic individuals. RESULTS: The clinical predictors of prevalent diabetes were age, BMI, family history of diabetes, WHR, and triacylglycerol/HDL-cholesterol ratio. After adjustment for these variables, the risk of diabetes was 2.7 (95% CI 1.8-4.0, p = 0.000006) for individuals with a genetic score within the top quintile, compared with the bottom quintile. Adding the genetic score to the clinical covariates improved the area under the receiver operating characteristic curve slightly (from 0.86 to 0.87), yet significantly (p = 0.002). BMI was similar in these two extreme quintiles. CONCLUSIONS/INTERPRETATION: In this population, a simple weighted 15 SNP-based genetic score provides additional information over clinical predictors of prevalent diabetes. At this stage, however, the clinical benefit of this genetic information is limited.
Assuntos
Diabetes Mellitus/epidemiologia , Diabetes Mellitus/genética , Polimorfismo de Nucleotídeo Único , Adulto , Idoso , Pressão Sanguínea , Índice de Massa Corporal , Diabetes Mellitus Tipo 2/epidemiologia , Diabetes Mellitus Tipo 2/genética , Feminino , Frequência do Gene , Marcadores Genéticos , Predisposição Genética para Doença/genética , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Suíça/epidemiologia , População Branca/estatística & dados numéricosRESUMO
Adverse drug reactions (ADRs) have a major impact on patients, physicians, health care providers, regulatory agencies and pharmaceutical companies. Identifying the genetic contributions to ADR risk may lead to a better understanding of the underlying mechanisms, identification of patients at risk and a decrease in the number of events. Technological advances have made the routine monitoring and investigation of the genetic basis of ADRs during clinical trials possible. We demonstrate through simulation that genome-wide genotyping, coupled with the use of clinically matched or population controls, can yield sufficient statistical power to permit the identification of strong genetic predictors of ADR risk in a prospective manner with modest numbers of ADR cases. The results of a 500,000 single nucleotide polymorphism analysis of abacavir-associated hypersensitivity reaction suggest that the known HLA-B gene region could be identified with as few as 15 cases and 200 population controls in a sequential analysis.
Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/genética , Genoma Humano , Farmacogenética/métodos , Polimorfismo de Nucleotídeo Único , Ensaios Clínicos como Assunto , DNA/genética , Didesoxinucleosídeos/efeitos adversos , Hipersensibilidade a Drogas/genética , Antígenos HLA-B/genética , HumanosRESUMO
The seventh sentence of the first paragraph of the letter from P. W. Anderson, E. Abrahams, and R. Laughlin that appeared in the issue of 1 March (pp. 1005-1006) was printed incorrectly. It should have read, "Others, such as the ;anyon' proponents, a group at Bell laboratories and Rutgers, and another at Princeton, are sure that this system is not a Fermi liquid."
Assuntos
Doença de Alzheimer , Células Cultivadas , HumanosRESUMO
A membrane-bound protein kinase occurs in membranes derived from rat skeletal muscle and appears limited to a surface membrane fraction. The enzyme is magnesium dependent, is only minimally stimulated by cyclic nucleotides, and phosphorylates serine and to a lesser extent threonine residues of three membrane proteins with molecular weights of less than 30,000.
Assuntos
Músculos/enzimologia , Proteínas Quinases/isolamento & purificação , Trifosfato de Adenosina/metabolismo , Animais , Fracionamento Celular , Membrana Celular/enzimologia , AMP Cíclico , GMP Cíclico , Eletroforese em Gel de Poliacrilamida , Ativação Enzimática , Magnésio , Peso Molecular , Músculos/citologia , Fosforilação Oxidativa , Peptídeos/metabolismo , Radioisótopos de Fósforo , Proteínas Quinases/metabolismo , Ratos , Serina/metabolismo , Treonina/metabolismoRESUMO
The apolipoprotein E type 4 allele (APOE-epsilon 4) is genetically associated with the common late onset familial and sporadic forms of Alzheimer's disease (AD). Risk for AD increased from 20% to 90% and mean age at onset decreased from 84 to 68 years with increasing number of APOE-epsilon 4 alleles in 42 families with late onset AD. Thus APOE-epsilon 4 gene dose is a major risk factor for late onset AD and, in these families, homozygosity for APOE-epsilon 4 was virtually sufficient to cause AD by age 80.
Assuntos
Alelos , Doença de Alzheimer/genética , Apolipoproteínas E/genética , Frequência do Gene , Idoso , Idoso de 80 Anos ou mais , Envelhecimento , Doença de Alzheimer/metabolismo , Doença de Alzheimer/mortalidade , Peptídeos beta-Amiloides/metabolismo , Apolipoproteína E4 , Apolipoproteínas E/fisiologia , Feminino , Genótipo , Homozigoto , Humanos , Desequilíbrio de Ligação , Masculino , Fatores de Risco , Taxa de SobrevidaRESUMO
Endothelin-1 (EDN1) has been reported to be implicated in the pathophysiology of asthma. Literature results on the genetic association of EDN1 in asthma are inconsistent. Eleven single nucleotide polymorphisms in EDN1 were genotyped in 342 and 100 families from UK and Norway, respectively. Asthma, bronchial hyperreactivity (BHR) and atopic asthma phenotypes were analyzed for the family-based association. Five single nucleotide polymorphisms (SNPs) were associated with asthma (0.0017Assuntos
Asma/genética
, Endotelina-1/genética
, Genética Populacional
, Polimorfismo de Nucleotídeo Único/genética
, Adolescente
, Adulto
, Alelos
, Estudos de Casos e Controles
, Criança
, Interpretação Estatística de Dados
, Família
, Feminino
, Frequência do Gene
, Marcadores Genéticos
, Haplótipos
, Humanos
, Desequilíbrio de Ligação
, Masculino
, Noruega
, Estatística como Assunto
, Reino Unido
RESUMO
The hypersensitivity (HSR) to abacavir (ABC) pharmacogenetics (PGx) program represents the progression from an exploratory discovery to a validated biomarker. Within the program, two retrospective PGx studies were conducted to identify HIV-1 patients at increased risk for ABC HSR, a treatment-limiting and potentially life-threatening adverse event. A strong statistical association between the major histocompatibility complex allele, HLA-B*5701, and clinically diagnosed ABC HSR was identified but varied between racial populations. Subsequently, ABC skin patch testing was introduced as a research tool to supplement clinical case ascertainment. In a randomized, prospective study evaluating the clinical utility of HLA-B*5701 screening, avoidance of ABC in HLA-B*5701-positive patients significantly reduced clinically diagnosed ABC HSR and eliminated patch test-positive ABC HSR. Finally, a retrospective PGx study supports the generalizability of the association across races. Prospective HLA-B*5701 screening should greatly reduce the incidence of ABC HSR by identifying patients at high risk for ABC HSR before they are treated.
Assuntos
Didesoxinucleosídeos/efeitos adversos , Hipersensibilidade a Drogas/genética , Farmacogenética , Inibidores da Transcriptase Reversa/efeitos adversos , Antígenos HLA-B/genética , Humanos , Testes do EmplastroRESUMO
I was invited to comment on the article in this issue by Larry Lesko, "Personalized Medicine: Elusive Dream or Imminent Reality?",(1) especially with respect to three questions. There are several possible approaches to discussing these questions. One is to simply answer the question as directly and succinctly as possible; another is to expand on the questions. For the purpose of this Commentary, I try to do both.
Assuntos
Pesquisa Biomédica/métodos , Indústria Farmacêutica/normas , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Preparações Farmacêuticas/administração & dosagem , Fármacos Anti-HIV/efeitos adversos , Fármacos Anti-HIV/uso terapêutico , Didesoxinucleosídeos/efeitos adversos , Didesoxinucleosídeos/uso terapêutico , Indústria Farmacêutica/economia , Humanos , Técnicas de Diagnóstico Molecular , Farmacogenética , Vigilância de Produtos Comercializados , Estudos Prospectivos , Ensaios Clínicos Controlados Aleatórios como AssuntoRESUMO
Myotonic muscular dystrophy (MyD) is a systemic genetic disorder that is thought to result from a generalized cellular membrane defect although the exact nature of this defect is unknown. This study examines two calcium-dependent membrane processes that have been observed in erythrocytes from healthy individuals: calcium-stimulated phosphatidic acid accumulation and calcium-induced potassium leak. We find that erythrocytes from MyD patients, in contrast to controls, have markedly impaired phosphatidic acid accumulations while maintaining normal potassium leaks. The calcium uptakes and ATP contents of MyD erythrocytes are not different from controls. We conclude that phospholipid metabolism is altered in MyD erythrocytes. The specificity of this abnormality and its relationship to altered muscular function are not known.
Assuntos
Membrana Eritrocítica/metabolismo , Eritrócitos/metabolismo , Lipídeos de Membrana/metabolismo , Miotonia Congênita/metabolismo , Ácidos Fosfatídicos/metabolismo , Transporte Biológico Ativo/efeitos dos fármacos , Cálcio/metabolismo , Cálcio/farmacologia , Humanos , Técnicas In Vitro , Potássio/metabolismoRESUMO
In myotonic muscular dystrophy, abnormal muscle Na currents underlie myotonic discharges. Since the myotonic muscular dystrophy gene encodes a product, human myotonin protein kinase, with structural similarity to protein kinases, we tested the idea that human myotonin protein kinase modulates skeletal muscle Na channels. Coexpression of human myotonin protein kinase with rat skeletal muscle Na channels in Xenopus oocytes reduced the amplitude of Na currents and accelerated current decay. The effect required the presence of a potential phosphorylation site in the inactivation mechanism of the channel. The mutation responsible for human disease, trinucleotide repeats in the 3' untranslated region, did not prevent the effect. The consequence of an abnormal amount of the kinase would be altered muscle cell excitability, consistent with the clinical finding of myotonia in myotonic dystrophy.
Assuntos
Músculo Esquelético/metabolismo , Distrofias Musculares/fisiopatologia , Proteínas Quinases/biossíntese , Proteínas Serina-Treonina Quinases , Sequências Repetitivas de Ácido Nucleico , Canais de Sódio/biossíntese , Animais , Encéfalo/metabolismo , Feto , Humanos , Potenciais da Membrana/fisiologia , Distrofias Musculares/genética , Mutação , Miocárdio/metabolismo , Miotonina Proteína Quinase , Oócitos/fisiologia , Técnicas de Patch-Clamp , Fosforilação , Proteínas Quinases/metabolismo , RNA Mensageiro/análise , RNA Mensageiro/biossíntese , Ratos , Mapeamento por Restrição , Canais de Sódio/fisiologia , XenopusRESUMO
Late-onset and sporadic Alzheimer's disease are associated with the apolipoprotein E (apoE) type 4 allele expressing the protein isoform apoE4. Apolipoprotein E binds avidly to beta amyloid (A beta) peptide, a major component of senile plaque of Alzheimer's disease, in an isoform-specific manner. The apoE4 isoform binds to A beta peptide more rapidly than apoE3. We observed that soluble SDS-stable complexes of apoE3 or apoE4, formed by coincubation with A beta peptide, precipitated after several days of incubation at 37 degrees C with apoE4 complexes precipitating more rapidly than apoE3 complexes. A beta(1-28) and A beta(1-40) peptides were incubated in the presence or absence of apoE3, apoE4, or bovine serum albumin for 4 d at 37 degrees C (pH 7.3). Negative stain electron microscopy revealed that the A beta peptide alone self-assembled into twisted ribbons containing two or three strands but occasionally into multistranded sheets. The apoE/A beta coincubates yielded monofibrils 7 nm in diameter. ApoE4/A beta coincubates yielded a denser matrix of monofibrils than apoE3/A beta coincubates. Unlike purely monofibrillar apoE4/A beta coincubates, apoE3/A beta coincubates also contained double- and triple-stranded structures. Both apoE isoforms were shown by immunogold labeling to be uniformly distributed along the A beta peptide monofibrils. Monofibrils appeared earlier in apoE4/A beta than in apoE3/A beta in time-course experiments. Thus apoE3 and apoE4 each interact with beta amyloid peptide to form novel monofibrillar structures, apoE4 more avidly, a finding consistent with the biochemical and genetic association between apoE4 and Alzheimer's disease.